Uncategorized

CES First Impressions

Before we get started with our first impression of CES here in Sin City let’s get the most stunning news out first. While visiting the Abbott booth an Abbott representative stated that Libre2 will not be here in the US for another year. This comment came in response to a question asked by an attendee, we just happened to standing next to the guy. Talk about luck but this is...

Who’s next?

As we make our final preparations for CES and JPM we can’t help but wonder which company is the next to implode and which will be the new rising star. Today we learned that digital health is still a hot topic as OneMedical has filed for an IPO. Yesterday we noted that Valeritas is headed for the insulin pump graveyard. Such is the circle of life one in, one out. Looking...

More money down the tubes

While folks in New England contemplate what to do now that the Patriots have been eliminated from the playoffs and begin to wonder whether their all world 42-year-old quarterback will retire, return for another season or heaven forbid dawn another teams jersey another New England based company has decided to call it quits. Word is spreading that Valeritas is about to call it quits. The last public information we have from...

No longer unique

With CES beginning next week other than reading stupid useless studies we’ve been prepping for the show trying to get some advance legwork done. Anyone who has been to CES knows this is one crazy show and there is no way to see it all. It is not an overstatement to say that CES literally takes over Sin City occupying nearly every inch of convention space. While doing this advanced legwork...

New Year New Decade Same Stupidity

Well the calendar has turned a page; the confetti has been swept from Times Square and we prepare for CES and JPM. Yes, it’s a new year, heck it’s a new decade but some things sadly never change. As everyone knows we aren’t overly fond of studies that lead to useless conclusions or studies which reach obvious conclusions. Yet for reasons we have never understood these useless studies keep getting...

The Golden Gate Beckons

The San Francisco 49ers aren’t the only thing happening when the New Year begins in that beautiful city by the bay. The day after the top seeded Niners play the lowest remaining seed in the NFL playoffs the J P Morgan Healthcare Conference opens at the Westin St. Francis. So after attending CES in Sin City which begins the week before we head to JPM with high expectations. The early schedule...

Out with the old, in with the new

As we close the book on 2019 and begin a new decade it’s worth looking back at the past decade and the many advancements in diabetes. There is no doubt in our mind that CGM was the most transformative technological innovation over the past decade. As we enter the new decade CGM systems are not just more accurate and patient friendly they are becoming more affordable an aspect that cannot...

Is this the beginning?

Yesterday an unexpected gift was found under the tree as according to a study published in Diabetes Research and Clinical Practice CGM could be used as a cancer prevention tool. This retrospective analysis done at a large teaching hospital in Tokyo, Japan concluded; “We found an association between large glycemic variability and a high risk of future malignancies in a dose-dependent manner among people without diabetes. This finding suggests that maintaining...

Tis was the night before ….

This being the Friday before Christmas and also Hanukah which begins Monday it’s time once again for our annual list of gifts. So let’s have at it – To Sean Salmon who is now running Medtronic Diabetes a year’s supply of Tums. Given you have inherited a mess of a unit you are going to need them. To Paul Hudson Sanofi’s new CEO who deserves credit for doing what needed to be...

What happens when the wheels fall off?

Digital health and by extension digital diabetes remains a hot topic. This is one reason we’re headed back to CES at the start of the new year and why this year’s edition of the J P Morgan Healthcare conference the following week should be more interesting than usual. Deals are being made, companies are accessing the capital markets and by the look of things this trend is far from over....